GE HealthCare Technologies GEHC
GE HealthCare Technologies is a medical technology company offering imaging, diagnostic, and patient monitoring solutions, as well as digital health services. GE HealthCare trades at a forward P/E of 12.31 and a FCF yield of 5.23%, suggesting an attractive valuation after a 28% decline; its ROE of 19.38% and the CareIntellect AI launch support a recovery thesis, though debt (ND/EBITDA 2.36) and the high-rate environment limit upside.
Detailed metrics
Market and fundamental data as of the analysis date.
Full AI report
Generated automatically from the metrics, the macro context and the company's news.
GE HealthCare Technologies is a medical technology company offering imaging, diagnostic, and patient monitoring solutions, as well as digital health services. GE HealthCare trades at a forward P/E of 12.31 and a FCF yield of 5.23%, suggesting an attractive valuation after a 28% decline; its ROE of 19.38% and the CareIntellect AI launch support a recovery thesis, though debt (ND/EBITDA 2.36) and the high-rate environment limit upside.
Score by category
| Category | Score |
|---|---|
| Financial health | 5.7 |
| Quality / Moat | 6.5 |
| Valuation | 6.9 |
| Growth | 6.7 |
| Dividend | 2.1 |
| Momentum | 4.9 |
| Risk & Context | 6.8 |
OVERALL SCORE: 6.1/10
Context and risks
The rise in 10-year Treasury yields (5.17%) affects GEHC due to its long-duration profile (P/E 15.35, not excessive) and debt (ND/EBITDA 2.36), but the effect is moderate. The main risk is regulatory: the medical devices sector is under pricing review and FDA scrutiny, adding uncertainty.
News considered in the analysis
- Veteran Needham analyst sees 44% upside in tumbling health stock — Upgrade de analista con objetivo de precio muy superior al actual; señala posible infravaloración tras la caída, pero es una opinión con probabilidad de materialización incierta.
- GE HealthCare (GEHC) is Down 28% and Wall Street is Starting to Buy. Is the Selloff Finally Over? — Artículo que sugiere que el interés de compra institucional podría marcar un punto de inflexión; refuerza la tesis de rebote, pero es especulativo.
- GEHC Could Be Set For A Turnaround — Needham Sees 44% Upside For GE Healthcare After Nearly 21% YTD Slide — Mismo análisis de Needham, ampliamente cubierto; el mercado ya lo descuenta parcialmente tras la caída del 21% YTD.
- Netflix downgraded, SanDisk initiated: Wall Street's top analyst calls — Listado genérico de llamadas de analistas sin información específica sobre GEHC.
- Is GE HealthCare Technologies (GEHC) Undervalued On Its CareIntellect AI Launch? — El lanzamiento de CareIntellect AI es un catalizador de producto con potencial de crecimiento; aún no está descontado en el precio.
Verdict: Hold or accumulate on dips; the valuation and quality profile is solid, but wait for confirmation that the selloff has bottomed before adding positions.
Main risk: The main risk is regulatory pricing pressure in medical devices and uncertainty over CareIntellect AI adoption, which may not deliver the expected growth.
Other Healthcare companies
Neighbours in the sector ranking, to compare without going back to the index.
See all 1,000+ companies in the index →